1150-P: Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Renal Outcomes in Patients with Type 2 Diabetes and Proteinuria

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Impact of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria

Diabetic Medicine ◽

10.1111/dme.14107 ◽

2019 ◽

Vol 37 (1) ◽

pp. 44-52 ◽

Cited By ~ 1

Author(s):

C. I. Coleman ◽

E. R. Weeda ◽

A. Kharat ◽

B. Bookhart ◽

W. L. Baker

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes

Current Hypertension Reports ◽

10.1007/s11906-002-0005-6 ◽

2002 ◽

Vol 4 (3) ◽

pp. 185-190 ◽

Cited By ~ 12

Author(s):

Jay Garg ◽

George L. Bakris

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2005.05.051 ◽

2005 ◽

Vol 46 (5) ◽

pp. 821-826 ◽

Cited By ~ 298

Author(s):

Hussam Abuissa ◽

Philip G. Jones ◽

Steven P. Marso ◽

James H. O’Keefe

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-Converting Enzyme Inhibitors Reduce Albuminuria More than Angiotensin Receptor Blockers in Patients with Type 2 Diabetes

Endocrine Practice ◽

10.4158/ep12272.or ◽

2013 ◽

Vol 19 (4) ◽

pp. 579-586 ◽

Cited By ~ 1

Author(s):

Nasreen AL-Sayed ◽

Tianming Gao ◽

Brian Wells ◽

Changhong Yu ◽

Robert Zimmerman

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Effect of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers on the Prevention of Death in Patients with Type 2 Diabetes and Undetermined Nephropathy : Five-Year Survival Data

Journal of Diabetes & Metabolism ◽

10.4172/2155-6156.1000188 ◽

2012 ◽

Vol 03 (04) ◽

Author(s):

Sirima Mongkolsomlit ◽

Petch Rawdaree ◽

Chulalux Komoltri

Keyword(s):

Type 2 Diabetes ◽

Survival Data ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2017.11.006 ◽

2018 ◽

Vol 42 (2) ◽

pp. 118-123 ◽

Cited By ~ 3

Author(s):

Thomas A. Mavrakanas ◽

Mark L. Lipman

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Treatment Of Hypertension ◽

Faculty Opinions recommendation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726264595.793522878 ◽

2016 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Myocardial Infarction ◽

Renal Dysfunction ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Cancer Epidemiology ◽

10.1016/j.canep.2009.10.005 ◽

2009 ◽

Vol 33 (5) ◽

pp. 391-395 ◽

Cited By ~ 14

Author(s):

E.R. Koomen ◽

R.M.C. Herings ◽

H.J. Guchelaar ◽

T. Nijsten

Keyword(s):

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Melanoma Incidence ◽

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2012.00687.x ◽

2012 ◽

Vol 14 (10) ◽

pp. 731-731 ◽

Cited By ~ 1

Author(s):

John J.V. McMurray ◽

Robert M. Califf ◽

Angelyn M. Bethel ◽

Steven M. Haffner ◽

Rury R. Holman

Keyword(s):

Cohort Study ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertension mega-trials with cardiovascular end points: Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

American Heart Journal ◽

10.1016/j.ahj.2004.04.037 ◽

2004 ◽

Vol 148 (5) ◽

pp. 747-754 ◽

Cited By ~ 47

Author(s):

Sverre E. Kjeldsen ◽

Stevo Julius

Keyword(s):

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

End Points ◽